Damora Therapeutics (DMRA) Earnings Date & Reports
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DMRA is expected to report earnings to rise 21.56% to -47 cents per share on October 30
Q3'26
Est.
$-0.47
Q2'26
Beat
by $0.05
Q1'26
Missed
by $0.30
Q4'25
Missed
by $135.47
The last earnings report on August 10 showed earnings per share of -38 cents, beating the estimate of -43 cents. With 77.19K shares outstanding, the current market capitalization sits at 1.90B.